Home › Compare › ILIM vs JNJ

ILIM vs JNJ: Dividend Comparison 2026

ILIM yields 500000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ILIM wins by $4.663521010693878e+33M in total portfolio value
10 years
ILIM
ILIM
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full ILIM calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ILIM vs JNJ

📍 ILIM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodILIMJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ILIM + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ILIM pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ILIM
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ILIM beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ILIM + JNJ for your $10,000?

ILIM: 50%JNJ: 50%
100% JNJ50/50100% ILIM
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ILIM
No analyst data
Altman Z
-390.1
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ILIM buys
0
JNJ buys
0
No recent congressional trades found for ILIM or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricILIMJNJ
Forward yield500000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.663521010693878e+33M$20.0K ✓
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.6634009849658873e+33M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ILIM vs JNJ ($10,000, DRIP)

YearILIM PortfolioILIM Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$50,010,700$50,000,000.00$10,676$355.77+$50.00M → ILIM
2$233,748,371,262$233,694,859,813.08$11,407$389.39+$233748.36M → ILIM
3$1,021,074,511,412,696$1,020,824,400,655,446.10$12,198$426.53+$1021074511.40M → ILIM
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$13,056$467.62+$4168597328794.94M → ILIM
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$13,987$513.12+$15905475114600664.00M → ILIM
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$14,998$563.56+$56718938532531060736.00M → ILIM
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$16,098$619.52+$1.8903180743562385e+23M → ILIM
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$17,295$681.69+$5.8879981047651824e+26M → ILIM
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$18,599$750.82+$1.7140642681147225e+30M → ILIM
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.663521010693878e+33M → ILIM

ILIM vs JNJ: Complete Analysis 2026

ILIM — Stock

il2m International Corp. operates as a music entertainment and social media company. The company develops, creates, and markets Ilink2music.com, a social media platform that allows users to unify their personal digital-mobile lifestyle while simultaneously providing exclusive international music entertainment content, networking, events, products, and services. Its platform enables the user to create a profile in the music entertainment zone that displays his/her talents or expertise. The company is based in Burbank, California.

Full ILIM Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ILIM vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ILIM vs SCHDILIM vs JEPIILIM vs OILIM vs KOILIM vs MAINILIM vs ABBVILIM vs MRKILIM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.